Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Biopsy TURBT Bladder Tumour

The Biopsy TURBT Bladder Tumour test examines tissue samples from the bladder to help diagnose bladder tumours. This procedure is essential for identifying the presence, type, and severity of potential tumours.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Tissue sample obtained via Transurethral Resection of Bladder Tumour (TURBT) procedure.
Results
Confirm with the laboratory before booking.
Preparation
This test requires a Doctor’s prescription. Please consult your doctor for specific preparation instructions, as this test is typically performed as part of a clinical procedure (TURBT).
Test priceKSh 8,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Biopsy TURBT Bladder Tumour test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Blood in urine (hematuria)
  • ✓Frequent urination
  • ✓Pain during urination
  • ✓Lower abdominal pain
  • ✓Suspicion of bladder tumour
  • ✓Follow-up after bladder tumour treatment
02

In plain language

What this test helps you understand

This test is used to diagnose bladder tumours, determine their type and grade, and guide treatment decisions. It is a key component in the management of bladder cancer.
The Biopsy TURBT Bladder Tumour test is a diagnostic procedure involving the removal and examination of a tissue sample from the bladder. This test is crucial for identifying the presence of bladder tumours and determining their type and severity. Early detection is vital for effective treatment and management of bladder cancer.

This test measures and detects the presence of abnormal cells and tissues in the bladder, which may indicate the presence of tumours. The analysis of the tissue sample is conducted through histopathology, allowing for a detailed examination of the cellular structure.

Individuals experiencing symptoms such as blood in urine (hematuria), frequent urination, pain during urination, or lower abdominal pain are advised to consult their healthcare provider about this test. Additionally, those with risk factors like a history of smoking, exposure to certain chemicals, or a family history of bladder cancer should also discuss this test with their doctor.

Benefits of taking this test include early detection of bladder tumours, which can significantly improve treatment outcomes. It provides crucial information for treatment planning, helps monitor the effectiveness of ongoing treatment, and offers peace of mind.

Your healthcare provider will explain the findings, including whether any abnormal cells were detected and what the next steps may be. It is important to discuss your results thoroughly to understand their implications for your health.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationThis test requires a Doctor’s prescription. Please consult your doctor for specific preparation instructions, as this test is typically performed as part of a clinical procedure (TURBT).
SampleTissue sample obtained via Transurethral Resection of Bladder Tumour (TURBT) procedure.
MethodologyHistopathology: Microscopic examination of the tissue sample by a pathologist.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
The accuracy of the test depends on the quality and representativeness of the tissue sample obtained. A negative result does not completely rule out the possibility of bladder cancer, especially if the sample was small or taken from an unaffected area.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

TURBT stands for Transurethral Resection of Bladder Tumour. It is a surgical procedure used to remove tumours from the bladder lining and obtain tissue samples for diagnosis.
Fasting is generally not required for the biopsy itself, but preparation instructions may vary depending on the TURBT procedure. Please consult your doctor.
The duration of your hospital stay after a TURBT procedure varies depending on the extent of the surgery and your individual recovery. Discuss this with your doctor.
The tissue sample is sent to the laboratory for analysis by a pathologist. Your doctor will discuss the results with you.
The TURBT procedure is performed under anaesthesia, so you should not feel pain during the procedure. You may experience some discomfort during recovery.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp